BLOOMA, LLC – Trademark Portfolio
Entity Type: 16
BLOOMA, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 4 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include BLOOMA. The owner is based in Minneapolis, MN.
5315 Lyndale Avenue South
Minneapolis, MN 55419
Showing of trademarks Trademarks
Trademark Classifications
BLOOMA, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Legal services; security services for the protection of property and individuals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does BLOOMA, LLC have?
BLOOMA, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 1 cancelled.
What trademark classes does BLOOMA, LLC file in?
BLOOMA, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 41 (Education & Entertainment), Class 45 (Legal & Security Services), Class 16 (Paper Goods). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are BLOOMA, LLC's most well-known trademarks?
BLOOMA, LLC's registered trademark portfolio includes well-known marks such as BLOOMA. These are among 2 currently registered trademarks in the portfolio.
What is BLOOMA, LLC's trademark registration success rate?
BLOOMA, LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.